Begin main content

Reports

We found 5640 result(s)

upadacitinib (TBC)

Last Updated: July 22, 2019
Result type: Reports
Product Line: Common Drug Review
Generic Name: upadacitinib
Indications: Arthritis, Rheumatoid

  • Brand Name: TBC
  • Manufacturer: AbbVie
  • Project Number: SR0614-000
  • Project Status: Active
  • Submission Type: New

insulin degludec + liraglutide (Xultophy)

Last Updated: July 19, 2019
Result type: Reports
Product Line: Common Drug Review
Generic Name: insulin degludec + liraglutide
Indications: Diabetes mellitus, Type 2

  • Brand Name: Xultophy
  • Manufacturer: Novo Nordisk Canada Inc.
  • Project Number: SR0599-000
  • Project Status: Active
  • Submission Type: NewCombination

cabotegravir sodium (TBC)

Last Updated: July 19, 2019
Result type: Reports
Product Line: Common Drug Review
Generic Name: cabotegravir sodium
Indications: HIV-1 infection

  • Brand Name: TBC
  • Manufacturer: ViiV Healthcare ULC
  • Project Number: SR0628-001
  • Project Status: Pending
  • Submission Type: NewCombination

esketamine hydrochloride (TBC )

Last Updated: July 18, 2019
Result type: Reports
Product Line: Common Drug Review
Generic Name: esketamine hydrochloride
Indications: Major depressive disorder (MDD), adults

  • Brand Name: TBC
  • Manufacturer: Janssen Inc.
  • Project Number: SR0621-000
  • Project Status: Active
  • Submission Type: New

tafamidis (TBC)

Last Updated: July 19, 2019
Result type: Reports
Product Line: Common Drug Review
Generic Name: tafamidis
Indications: transthyretin-mediated amyloidosis

  • Brand Name: TBC
  • Manufacturer: Pfizer Canada
  • Project Number: SR0625-000
  • Project Status: Active
  • Submission Type: New

cyclosporine (Verkazia)

Last Updated: July 19, 2019
Result type: Reports
Product Line: Common Drug Review
Generic Name: cyclosporine
Indications: Severe vernal keratoconjunctivitis, pediatric (≥4 years)

  • Brand Name: Verkazia
  • Manufacturer: Santen Inc.
  • Project Number: SR0615-000
  • Project Status: Active
  • Submission Type: New

ravulizumab (TBC)

Last Updated: July 19, 2019
Result type: Reports
Product Line: Common Drug Review
Generic Name: ravulizumab
Indications: Paroxysmal nocturnal hemoglobinuria.

  • Brand Name: TBC
  • Manufacturer: Alexion Pharma Canada Corp
  • Project Number: SR0623-000
  • Project Status: Active
  • Submission Type: New

ulipristal acetate (Fibristal)

Last Updated: July 18, 2019
Result type: Reports
Product Line: Common Drug Review
Generic Name: ulipristal acetate
Indications: Uterine fibroids (signs and symptoms)

  • Brand Name: Fibristal
  • Manufacturer: Allergan Inc.
  • Project Number: SF0609-000
  • Project Status: Active
  • Submission Type: RequestForAdvice